BALENTINE LLC – Regeneron Pharmaceuticals, Inc. Transaction History
BALENTINE LLC portfolio value:
$2.21M
portfolio value
BALENTINE LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.94% | -655 shares | -73K | $688.87 | 3.21K |
| Q2 2022 | share | Increase | +69.64% | 1.58K shares | 693K | $591.13 | 3.86K |
| Q1 2022 | share | Increase | +263.48% | 1.65K shares | 1.19M | $698.42 | 2.27K |
| Q4 2021 | share | Increase | +7.55% | 44 shares | 43K | $642.51 | 627 |
| Q3 2021 | share | Increase | 0.00% | 583 shares | 353K | $605.18 | 583 |
| Q3 2020 | share | Decrease | -100.00% | -99 shares | -62K | $559.78 | 0 |
| Q2 2020 | share | Increase | +10.00% | 9 shares | 18K | $623.65 | 99 |
| Q1 2020 | share | Increase | +2150.00% | 86 shares | 42K | $488.29 | 90 |
| Q4 2019 | share | 0.00% | 0 shares | 1K | $375.48 | 4 | |
| Q3 2019 | share | Decrease | -42.86% | -3 shares | -1K | $277.4 | 4 |
| Q2 2019 | share | Increase | 0.00% | 7 shares | 2K | $313 | 7 |
| Q1 2018 | share | Decrease | -100.00% | -31 shares | -12K | $344.36 | 0 |
| Q4 2017 | share | Decrease | -46.55% | -27 shares | -14K | $375.96 | 31 |
| Q3 2017 | share | 0.00% | 0 shares | -2K | $447.12 | 58 | |
| Q2 2017 | share | 0.00% | 0 shares | 6K | $491.14 | 58 | |
| Q1 2017 | share | Increase | +114.81% | 31 shares | 12K | $387.51 | 58 |
| Q4 2016 | share | 0.00% | 0 shares | -1K | $367.09 | 27 | |
| Q3 2016 | share | 0.00% | 0 shares | 2K | $402.02 | 27 | |
| Q2 2016 | share | Increase | 0.00% | 27 shares | 9K | $349.23 | 27 |
| Q1 2016 | share | Decrease | -100.00% | -74 shares | -40K | $360.44 | 0 |